The University of Bristol is a red brick Russell Group research university in Bristol, England. It received its royal charter in 1909, although it can trace its roots to a Merchant Venturers' school founded in 1595 and University College, Bristol, which had been in existence since 1876.

During the past decade, University of Bristol conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Bristol" #1 sponsor was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials, followed by "Bournemouth University" with 1 trials sponsored, "Janssen-Cilag Ltd." with 1 trials sponsored, "Lateral Pharma Pty Ltd" with 1 trials sponsored and "University of Bristol" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Bristol" #1 collaborator was "National Center for Research Resources (NCRR)" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "American Diabetes Association" with 2 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University of Bristol" are "Diabetes Mellitus, Type 1" (3 trials), "Children" (1 trials), "Depressive Disorder, Treatment-Resistant" (1 trials), "Diabetic Peripheral Neuropathy (DPN)" (1 trials) and "Neuropathic Pain" (1 trials). Many other conditions were trialed in "University of Bristol" in a lesser frequency.

Most popular intervention types in "University of Bristol" are "Drug" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cellular Immunoblot Assays" (1 trials), "Cytokine ELISPOT" (1 trials), "Glucagon Stimulation Test" (1 trials) and "LAT8881" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Bristol" are 8 trials for "All" genders.

Currently, there are NaN active trials in "University of Bristol". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Bristol, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Bristol, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

University of Bristol has several departments that took part in Clinical trials: "Bristol Children's Vaccine Centre, University of Bristol" - 2 trials, "School of Oral and Dental Science" - 2 trials